The Motley Fool
Search documents
Artificial Intelligence (AI) Is Changing Corporate Spending Priorities. This Stock Stands to Gain.
The Motley Fool· 2026-02-10 00:30
Nvidia should continue to benefit from a surge in artificial intelligence (AI) spending.It's no surprise that corporate spending directed toward artificial intelligence (AI) is ramping up. Companies across nearly all sectors are trying to position themselves as leaders in AI, or at least not get left behind, and that's causing many to spend piles of cash to stay competitive.One company that's already seen a huge surge in demand for AI hardware as a result of this spending is Nvidia (NVDA +2.58%), and more c ...
Why Astera Labs Stock Surged on Monday
The Motley Fool· 2026-02-10 00:22
Investors were clearly looking forward to the company's earnings release after market close on Tuesday.Semiconductor stock Astera Labs (ALAB +10.49%) notched a nearly 10% price gain on Monday, the day before it's slated to publish its latest earnings release. Optimism about the numbers the company will post, plus news of expansion abroad, helped drive that near-double-digit lift.Researching how to growThat morning, California-based Astera announced that it had opened an advanced research and development (R& ...
Provident Dumps 490,000 MapleBear Shares Worth $18 Million
The Motley Fool· 2026-02-10 00:06
Maplebear Inc. connects North American households with personal shoppers through its technology-driven grocery delivery platform.On February 4, 2026, Provident Investment Management, Inc. sold out its entire stake in Maplebear (CART +1.46%).What happenedAccording to a recent SEC filing dated February 4, 2026, Provident Investment Management, Inc. liquidated its holdings in Maplebear, selling 489,560 shares. The estimated transaction value is approximately $18.00 million, based on the average share price dur ...
Why Pagaya Technologies Stock Plummeted by Almost 24% Today
The Motley Fool· 2026-02-09 22:41
Core Insights - Pagaya Technologies reported quarterly results that fell short of market expectations, resulting in a nearly 24% decline in share price [1] Financial Performance - The company generated $335 million in total revenue and other income for the fourth quarter, marking a 20% year-over-year increase [2] - Network volume increased by only 3% to $2.7 billion, which was below expectations [2] - Non-GAAP net income rose almost sixfold to nearly $78.8 million, or $0.80 per share, surpassing the consensus estimate of $0.35 per share [4] Strategic Changes - The slower growth in network volume and the disparity between revenue and net income growth rates were attributed to Pagaya's strategic exit from its single-family rental (SFR) operations [5] Future Guidance - For the first quarter, Pagaya anticipates network volume to be flat or slightly down, ranging from $2.5 billion to $2.7 billion, with revenue projected between $315 million and $335 million [7] - The company's guidance for the full year includes a network volume range of $11.25 billion to $13 billion and revenue expectations of $1.4 billion to nearly $1.58 billion [8]
Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit
The Motley Fool· 2026-02-09 22:30
Core Viewpoint - Hims & Hers is facing significant challenges after withdrawing its weight-loss pill due to legal action and FDA scrutiny, leading to a sharp decline in stock price and market reevaluation by investors [1][5]. Company Performance - Hims & Hers Health's stock closed at $19.32, down 16.07%, with a market cap of $5.2 billion [2]. - The stock has dropped 26.89% over the past five days, primarily due to legal and regulatory pressures [5]. - Trading volume reached 143.5 million shares, significantly above the three-month average of 18.2 million shares [3]. Regulatory and Legal Issues - The company announced the withdrawal of its copycat version of the obesity drug Wegovy amid regulatory pressure [5]. - A lawsuit from Novo Nordisk seeks to ban Hims & Hers from selling compounded copies of its patented drugs [6]. - The FDA has indicated a crackdown on unauthorized use of GLP-1 active pharmaceutical ingredients, impacting Hims & Hers' operations [6]. Strategic Shift - Hims & Hers plans to pivot away from controversial compounded medicines and focus on other health conditions and AI health capabilities [6].
Waymo Just Raised Another $16 Billion. Does That Make Alphabet the Ultimate AI Stock for 2026?
The Motley Fool· 2026-02-09 22:30
Core Insights - Waymo's recent capital raise of $16 billion highlights Alphabet's significant AI opportunities, with Waymo's valuation now at $126 billion, more than double its value from two years ago [1][2] Group 1: Waymo's Expansion and Impact - Waymo completed 15 million rides last year, a more than 3x increase from the previous year, showcasing the effectiveness of its self-driving technology [4] - The new investment will enable Waymo to expand its operations to 20 additional U.S. cities and internationally, transitioning from proving a concept to scaling a commercial reality [5] - The autonomous vehicle market is projected to be worth $2.2 trillion by 2030, presenting a substantial opportunity for Waymo and Alphabet [6] Group 2: Alphabet's Broader AI Strategy - Alphabet's chatbot, Google Gemini, has seen rapid growth, with 750 million monthly active users, up from 400 million nine months ago, indicating strong user engagement and ecosystem strength [9] - A collaboration with Apple will see Gemini used as the AI model for a new version of Siri, with Alphabet expected to receive billions over several years [10] - Alphabet's cloud revenue surged 48% in Q4, reaching $17.6 billion, contributing to over $400 billion in annual revenue for 2025, underscoring the financial impact of its AI initiatives [11]
Stock Market Today, Feb. 9: Kyndryl Share Price Halved After Earnings Miss and Delayed Filing
The Motley Fool· 2026-02-09 22:26
Core Viewpoint - Kyndryl, an IT infrastructure and cloud services provider, is facing significant challenges including a sharp decline in stock price, missed earnings expectations, an accounting review, and leadership changes, leading to increased legal scrutiny [2][5]. Financial Performance - Kyndryl's stock closed at $10.59, down 54.94% after earnings and revenue missed estimates, with revenue only rising 3% [2][5]. - The company has a market capitalization of $5.4 billion and a gross margin of 21.50% [2]. - Trading volume reached 59.3 million shares, significantly above the three-month average of 3.2 million shares [3]. Leadership and Governance - The company announced a leadership shake-up in its finance and legal departments, including the departure of the CFO, following the disclosure of material weaknesses in internal controls [5]. - The delay in filing the Form 10-Q has raised concerns among investors and led to securities-fraud investigations by multiple law firms [5]. Market Context - The broader U.S. markets showed slight gains, with the S&P 500 up 0.45% and the Nasdaq Composite rising 0.90%, indicating pressure across traditional IT services providers [4]. - Kyndryl's stock has fallen 74% since its IPO in 2021, reflecting ongoing challenges in the IT services sector [3]. Valuation Perspective - Kyndryl is currently viewed as deeply discounted in terms of valuation, but uncertainty surrounding the recent issues has led to a cautious stance among investors [6].
BND Offers Broader Bond Mix Than VGIT
The Motley Fool· 2026-02-09 20:19
Core Viewpoint - Vanguard Total Bond Market ETF (BND) offers broader exposure to the U.S. bond market compared to Vanguard Intermediate-Term Treasury ETF (VGIT), which focuses on intermediate-term Treasuries, providing distinct options for income seekers [1]. Cost and Size - Both BND and VGIT have an expense ratio of 0.03% [3][4]. - BND has a current price of $74.24, with a 1-year return of 2.3% and a dividend yield of 4.2% [2][4]. - VGIT has a 1-year return of 2.5% and a dividend yield of 3.9% [3]. Performance and Risk Comparison - Over the past five years, BND experienced a maximum drawdown of -17.29%, while VGIT had a lower drawdown of -14.77% [5]. - The growth of $1,000 over five years was $994 for BND and $998 for VGIT, indicating similar performance despite BND's broader exposure [5]. Portfolio Composition - BND holds 11,444 different bonds with an average effective maturity of eight years, with 49.2% in Treasury bonds, 19.5% in government mortgage-backed securities, and 14.5% in industrial bonds [6]. - VGIT primarily consists of intermediate-term U.S. Treasuries, with only 102 positions, focusing on maximum safety from credit risk [7]. Investment Implications - BND's diversification and higher yield of 4.2% make it a more attractive option for income investors compared to VGIT's yield of 3.9% [8]. - BND's average duration of 5.7 years suggests less sensitivity to interest rate changes compared to VGIT's 4.9 years [9]. - VGIT's lower drawdowns and volatility may appeal to conservative investors, but BND could provide higher upside if interest rates decline [10].
Is Intuitive Machines Stock a Buy After the University of Pennsylvania Purchased 2.6 Million Shares?
The Motley Fool· 2026-02-09 20:14
Core Insights - Intuitive Machines is experiencing increased investment interest, highlighted by the University of Pennsylvania's significant stake increase, indicating a bullish outlook on the stock [2][7] - Despite a challenging one-year performance, the company's shares have surged in 2026, driven by excitement in the space sector and recent contract wins [10][11] Company Overview - Intuitive Machines is a Houston-based aerospace company focused on lunar and space infrastructure solutions, leveraging advanced engineering for reliable access to lunar exploration [6] - The company operates in the aerospace and defense sector, providing services such as lunar access, orbital services, and space products [9] Financial Metrics - As of February 5, 2026, the company's stock price was $14.79, with a market capitalization of $2.81 billion [4] - The company reported a revenue of $218.49 million and a net income of -$193.22 million for the trailing twelve months [4] Investment Activity - The University of Pennsylvania's Trustees increased their stake in Intuitive Machines by 2,571,424 shares, raising their total investment to $52.69 million, which is 25.87% of the fund's reportable assets under management [2][3] - The stock's price-to-sales ratio is around 10, indicating a high valuation compared to the previous year [11]
Prediction: This Chip Stock Could Be a Top Performer by 2027
The Motley Fool· 2026-02-09 10:19
Group 1: Company Overview - Texas Instruments (TXN) has seen its shares rebound to all-time highs, indicating potential for further gains in the context of the AI revolution [1] - The company specializes in analog chips, which convert physical events into digital signals, and are essential in various tech products [2] - Texas Instruments' chips play a crucial role in power management within data centers that support AI infrastructure, suggesting a long-term growth opportunity as AI development continues [4] Group 2: Growth and Investment - The analog chip sector has faced challenges in recent years, but Texas Instruments is investing in new production capacity and has agreed to acquire competitor Silicon Labs [5] - The company has restructured its reporting to highlight its data center business, which accounted for approximately 9% of total revenue and experienced a 64% year-over-year growth in the fourth quarter [6] - Despite the nascent nature of the AI opportunity, revenue from the data center segment rose by a mid-single-digit percentage from the previous quarter, indicating potential for significant growth in the analog chip sector [8] Group 3: Market Position and Future Outlook - Texas Instruments is recognized as a leader in the analog chip market, positioning itself for long-term success despite competition from other chipmakers [9] - The ongoing AI buildout could elevate Texas Instruments to a top-performing chipmaker by 2027, driven by the strength of its business and growth initiatives [9]